Top Story

FDA approves Rituxan for pemphigus vulgaris

FDA approves Rituxan for pemphigus vulgaris
June 8, 2018
Meeting News

IAS 2018: Advances, collaboration in immune-mediated inflammatory diseases

April 26, 2018
BOSTON — Rheumatologists, gastroenterologists, dermatologists, immunologists and other health care providers who care for patients with immune-mediated…
FDA News

FDA declines proposed Rituxan, Herceptin biosimilars from Celltrion

April 6, 2018
The FDA has rejected approval of Celltrion’s biologics license applications for Truxima, a proposed rituximab biosimilar, and Herzuma, a proposed trastuzumab…
In the Journals

Stem cell transplant improves overall, event-free survival in scleroderma

January 3, 2018
Myeloablative autologous stem cell transplantation improved long-term clinical outcomes, including overall survival and event-free survival, among patients with diffuse…
More Headlines »
Healio Jobs